Do analysts rate APT or EMBC?

Embecta has a consensus price target of $11.00, suggesting a potential upside of 192.16%. Given Embecta's stronger consensus rating and higher possible upside, analysts plainly believe Embecta is more favorable than Alpha Pro Tech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Pro Tech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Embecta 2 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.60

Which has better earnings & valuation, APT or EMBC?

Embecta has higher revenue and earnings than Alpha Pro Tech. Embecta is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alpha Pro Tech $59.91M 0.86 $4.19M $0.35 14.33 Embecta $1.08B 0.21 $95.40M $1.90 1.98

Is APT or EMBC more profitable?

Embecta has a net margin of 10.73% compared to Alpha Pro Tech's net margin of 6.99%. Alpha Pro Tech's return on equity of 6.70% beat Embecta's return on equity. Company Net Margins Return on Equity Return on Assets Alpha Pro Tech 6.99% 6.70% 5.76% Embecta 10.73% -23.96% 14.12%

Do analysts prefer INFU or APT?

InfuSystem presently has a consensus price target of $15.00, indicating a potential upside of 38.88%. Given InfuSystem's stronger consensus rating and higher probable upside, research analysts clearly believe InfuSystem is more favorable than Alpha Pro Tech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InfuSystem 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Alpha Pro Tech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts rate APT or LUCD?

Lucid Diagnostics has a consensus target price of $4.19, suggesting a potential upside of 341.25%. Given Lucid Diagnostics' stronger consensus rating and higher probable upside, analysts plainly believe Lucid Diagnostics is more favorable than Alpha Pro Tech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Pro Tech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Lucid Diagnostics 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60

Do analysts recommend APT or PDEX?

Pro-Dex has a consensus target price of $70.00, suggesting a potential upside of 8.07%. Given Pro-Dex's stronger consensus rating and higher probable upside, analysts clearly believe Pro-Dex is more favorable than Alpha Pro Tech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Pro Tech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Pro-Dex 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has stronger valuation & earnings, APT or PDEX?

Pro-Dex has higher revenue and earnings than Alpha Pro Tech. Alpha Pro Tech is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alpha Pro Tech $59.91M 0.86 $4.19M $0.35 14.33 Pro-Dex $66.59M 3.10 $8.98M $3.62 17.89

Is APT or PDEX more profitable?

Pro-Dex has a net margin of 16.08% compared to Alpha Pro Tech's net margin of 6.99%. Pro-Dex's return on equity of 22.78% beat Alpha Pro Tech's return on equity. Company Net Margins Return on Equity Return on Assets Alpha Pro Tech 6.99% 6.70% 5.76% Pro-Dex 16.08% 22.78% 14.30%

Do analysts rate APT or KRMD?

KORU Medical Systems has a consensus price target of $7.25, suggesting a potential upside of 69.91%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, analysts clearly believe KORU Medical Systems is more favorable than Alpha Pro Tech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Pro Tech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 KORU Medical Systems 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60

Alpha Pro Tech (APT) Competitors

$4.98 +0.05 (+0.93%)

As of 10:26 AM Eastern

Compare

APT vs. EMBC, INFU, LUCD, PDEX, and KRMD

Should you buy Alpha Pro Tech stock or one of its competitors? MarketBeat compares Alpha Pro Tech with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alpha Pro Tech include Embecta (EMBC), InfuSystem (INFU), Lucid Diagnostics (LUCD), Pro-Dex (PDEX), and KORU Medical Systems (KRMD).

How does Alpha Pro Tech compare to Embecta?

Alpha Pro Tech (NYSE:APT) and Embecta (NASDAQ:EMBC) are related small-cap companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability.

Embecta has higher revenue and earnings than Alpha Pro Tech. Embecta is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Pro Tech	$59.91M	0.86	$4.19M	$0.35	14.33
Embecta	$1.08B	0.21	$95.40M	$1.90	1.98

In the previous week, Embecta had 38 more articles in the media than Alpha Pro Tech. MarketBeat recorded 38 mentions for Embecta and 0 mentions for Alpha Pro Tech. Embecta's average media sentiment score of 0.04 beat Alpha Pro Tech's score of 0.00 indicating that Embecta is being referred to more favorably in the news media.

Company	Overall Sentiment
Alpha Pro Tech	Neutral
Embecta	Neutral

Embecta has a net margin of 10.73% compared to Alpha Pro Tech's net margin of 6.99%. Alpha Pro Tech's return on equity of 6.70% beat Embecta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Pro Tech	6.99%	6.70%	5.76%
Embecta	10.73%	-23.96%	14.12%

Alpha Pro Tech has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market. Comparatively, Embecta has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market.

Embecta has a consensus price target of $11.00, suggesting a potential upside of 192.16%. Given Embecta's stronger consensus rating and higher possible upside, analysts plainly believe Embecta is more favorable than Alpha Pro Tech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Pro Tech	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Embecta	2 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.60

22.7% of Alpha Pro Tech shares are held by institutional investors. Comparatively, 93.8% of Embecta shares are held by institutional investors. 16.2% of Alpha Pro Tech shares are held by company insiders. Comparatively, 1.3% of Embecta shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Embecta beats Alpha Pro Tech on 10 of the 15 factors compared between the two stocks.

How does Alpha Pro Tech compare to InfuSystem?

InfuSystem (NYSE:INFU) and Alpha Pro Tech (NYSE:APT) are related small-cap companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, media sentiment, dividends, valuation, analyst recommendations, risk and earnings.

InfuSystem has a beta of 1.4, indicating that its share price is 40% more volatile than the broader market. Comparatively, Alpha Pro Tech has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market.

In the previous week, InfuSystem had 1 more articles in the media than Alpha Pro Tech. MarketBeat recorded 1 mentions for InfuSystem and 0 mentions for Alpha Pro Tech. InfuSystem's average media sentiment score of 0.00 equaled Alpha Pro Tech'saverage media sentiment score.

Company	Overall Sentiment
InfuSystem	Neutral
Alpha Pro Tech	Neutral

InfuSystem presently has a consensus price target of $15.00, indicating a potential upside of 38.88%. Given InfuSystem's stronger consensus rating and higher probable upside, research analysts clearly believe InfuSystem is more favorable than Alpha Pro Tech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InfuSystem	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Alpha Pro Tech	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Alpha Pro Tech has a net margin of 6.99% compared to InfuSystem's net margin of 1.12%. Alpha Pro Tech's return on equity of 6.70% beat InfuSystem's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InfuSystem	1.12%	2.78%	1.41%
Alpha Pro Tech	6.99%	6.70%	5.76%

Alpha Pro Tech has lower revenue, but higher earnings than InfuSystem. Alpha Pro Tech is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InfuSystem	$142.40M	1.53	$870K	$0.38	28.42
Alpha Pro Tech	$59.91M	0.86	$4.19M	$0.35	14.33

71.1% of InfuSystem shares are owned by institutional investors. Comparatively, 22.7% of Alpha Pro Tech shares are owned by institutional investors. 10.8% of InfuSystem shares are owned by insiders. Comparatively, 16.2% of Alpha Pro Tech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

InfuSystem beats Alpha Pro Tech on 10 of the 15 factors compared between the two stocks.

How does Alpha Pro Tech compare to Lucid Diagnostics?

Alpha Pro Tech (NYSE:APT) and Lucid Diagnostics (NASDAQ:LUCD) are related small-cap companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings.

Alpha Pro Tech has higher revenue and earnings than Lucid Diagnostics. Lucid Diagnostics is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Pro Tech	$59.91M	0.86	$4.19M	$0.35	14.33
Lucid Diagnostics	$4.71M	40.92	-$58.01M	-$0.47	N/A

In the previous week, Lucid Diagnostics had 3 more articles in the media than Alpha Pro Tech. MarketBeat recorded 3 mentions for Lucid Diagnostics and 0 mentions for Alpha Pro Tech. Lucid Diagnostics' average media sentiment score of 0.45 beat Alpha Pro Tech's score of 0.00 indicating that Lucid Diagnostics is being referred to more favorably in the news media.

Company	Overall Sentiment
Alpha Pro Tech	Neutral
Lucid Diagnostics	Neutral

Alpha Pro Tech has a net margin of 6.99% compared to Lucid Diagnostics' net margin of -876.72%. Alpha Pro Tech's return on equity of 6.70% beat Lucid Diagnostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Pro Tech	6.99%	6.70%	5.76%
Lucid Diagnostics	-876.72%	N/A	-116.26%

22.7% of Alpha Pro Tech shares are owned by institutional investors. Comparatively, 74.0% of Lucid Diagnostics shares are owned by institutional investors. 16.2% of Alpha Pro Tech shares are owned by company insiders. Comparatively, 6.9% of Lucid Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Lucid Diagnostics has a consensus target price of $4.19, suggesting a potential upside of 341.25%. Given Lucid Diagnostics' stronger consensus rating and higher probable upside, analysts plainly believe Lucid Diagnostics is more favorable than Alpha Pro Tech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Pro Tech	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Lucid Diagnostics	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Alpha Pro Tech has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market. Comparatively, Lucid Diagnostics has a beta of 1.08, indicating that its stock price is 8% more volatile than the broader market.

Summary

Alpha Pro Tech and Lucid Diagnostics tied by winning 8 of the 16 factors compared between the two stocks.

How does Alpha Pro Tech compare to Pro-Dex?

Alpha Pro Tech (NYSE:APT) and Pro-Dex (NASDAQ:PDEX) are related small-cap companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk and valuation.

Pro-Dex has a net margin of 16.08% compared to Alpha Pro Tech's net margin of 6.99%. Pro-Dex's return on equity of 22.78% beat Alpha Pro Tech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Pro Tech	6.99%	6.70%	5.76%
Pro-Dex	16.08%	22.78%	14.30%

22.7% of Alpha Pro Tech shares are held by institutional investors. Comparatively, 15.3% of Pro-Dex shares are held by institutional investors. 16.2% of Alpha Pro Tech shares are held by insiders. Comparatively, 45.9% of Pro-Dex shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Pro-Dex has higher revenue and earnings than Alpha Pro Tech. Alpha Pro Tech is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Pro Tech	$59.91M	0.86	$4.19M	$0.35	14.33
Pro-Dex	$66.59M	3.10	$8.98M	$3.62	17.89

Alpha Pro Tech has a beta of 0.87, meaning that its share price is 13% less volatile than the broader market. Comparatively, Pro-Dex has a beta of 0.02, meaning that its share price is 98% less volatile than the broader market.

In the previous week, Pro-Dex had 2 more articles in the media than Alpha Pro Tech. MarketBeat recorded 2 mentions for Pro-Dex and 0 mentions for Alpha Pro Tech. Alpha Pro Tech's average media sentiment score of 0.00 equaled Pro-Dex'saverage media sentiment score.

Company	Overall Sentiment
Alpha Pro Tech	Neutral
Pro-Dex	Neutral

Pro-Dex has a consensus target price of $70.00, suggesting a potential upside of 8.07%. Given Pro-Dex's stronger consensus rating and higher probable upside, analysts clearly believe Pro-Dex is more favorable than Alpha Pro Tech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Pro Tech	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Pro-Dex	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Pro-Dex beats Alpha Pro Tech on 13 of the 15 factors compared between the two stocks.

How does Alpha Pro Tech compare to KORU Medical Systems?

Alpha Pro Tech (NYSE:APT) and KORU Medical Systems (NASDAQ:KRMD) are related small-cap companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings.

Alpha Pro Tech has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Pro Tech	$59.91M	0.86	$4.19M	$0.35	14.33
KORU Medical Systems	$41.13M	4.76	-$2.64M	-$0.05	N/A

22.7% of Alpha Pro Tech shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 16.2% of Alpha Pro Tech shares are owned by company insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, KORU Medical Systems had 4 more articles in the media than Alpha Pro Tech. MarketBeat recorded 4 mentions for KORU Medical Systems and 0 mentions for Alpha Pro Tech. KORU Medical Systems' average media sentiment score of 0.65 beat Alpha Pro Tech's score of 0.00 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company	Overall Sentiment
Alpha Pro Tech	Neutral
KORU Medical Systems	Positive

KORU Medical Systems has a consensus price target of $7.25, suggesting a potential upside of 69.91%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, analysts clearly believe KORU Medical Systems is more favorable than Alpha Pro Tech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Pro Tech	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Alpha Pro Tech has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.45, indicating that its stock price is 55% less volatile than the broader market.

Alpha Pro Tech has a net margin of 6.99% compared to KORU Medical Systems' net margin of -5.27%. Alpha Pro Tech's return on equity of 6.70% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Pro Tech	6.99%	6.70%	5.76%
KORU Medical Systems	-5.27%	-13.61%	-8.33%

Summary

Alpha Pro Tech and KORU Medical Systems tied by winning 8 of the 16 factors compared between the two stocks.

Get Alpha Pro Tech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

APT vs. The Competition

Export

Metric	Alpha Pro Tech	Building Products Industry	Industrials Sector	NYSE Exchange
Market Cap	$50.78M	$8.47B	$10.55B	$23.73B
Dividend Yield	N/A	2.14%	120.66%	4.21%
P/E Ratio	13.43	64.60	27.80	31.49
Price / Sales	0.86	19.30	311.88	14.39
Price / Cash	12.80	14.79	24.04	18.72
Price / Book	0.95	7.59	4.84	4.83
Net Income	$4.19M	$4.96B	$610.20M	$1.07B
7 Day Performance	0.28%	0.49%	1.08%	0.34%
1 Month Performance	-8.84%	-0.24%	-1.21%	0.59%
1 Year Performance	2.96%	1.79%	12.74%	18.76%

Alpha Pro Tech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
APT Alpha Pro Tech	N/A	$4.98 +0.9%	N/A	+2.1%	$51.02M	$59.91M	13.50	120
EMBC Embecta	4.1394 of 5 stars	$3.33 +2.3%	$11.00 +230.8%	-62.7%	$197.87M	$1.08B	1.76	1,850	Trending News Upcoming Earnings
INFU InfuSystem	4.0553 of 5 stars	$9.20 +3.5%	$15.00 +63.0%	+61.8%	$185.72M	$142.40M	153.39	410	News Coverage
LUCD Lucid Diagnostics	3.5241 of 5 stars	$0.91 -3.9%	$4.19 +360.7%	-3.2%	$184.59M	$4.71M	N/A	70	News Coverage Gap Up
PDEX Pro-Dex	1.4519 of 5 stars	$55.85 +2.2%	$70.00 +25.3%	+34.3%	$178.16M	$66.59M	15.43	140	News Coverage High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:APT) was last updated on 8/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alpha Pro Tech (APT) Competitors

APT vs. EMBC, INFU, LUCD, PDEX, and KRMD

How does Alpha Pro Tech compare to Embecta?

Summary

How does Alpha Pro Tech compare to InfuSystem?

Summary

How does Alpha Pro Tech compare to Lucid Diagnostics?

Summary

How does Alpha Pro Tech compare to Pro-Dex?

Summary

How does Alpha Pro Tech compare to KORU Medical Systems?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

APT vs. The Competition

Alpha Pro Tech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alpha Pro Tech (APT) Competitors

APT vs. EMBC, INFU, LUCD, PDEX, and KRMD

How does Alpha Pro Tech compare to Embecta?

Which has better earnings & valuation, APT or EMBC?

Does the media refer more to APT or EMBC?

Is APT or EMBC more profitable?

Which has more volatility and risk, APT or EMBC?

Do analysts rate APT or EMBC?

Do insiders & institutionals believe in APT or EMBC?

Summary

How does Alpha Pro Tech compare to InfuSystem?

Which has more risk and volatility, INFU or APT?

Does the media prefer INFU or APT?

Do analysts prefer INFU or APT?

Is INFU or APT more profitable?

Which has higher valuation and earnings, INFU or APT?

Do insiders and institutionals believe in INFU or APT?

Summary

How does Alpha Pro Tech compare to Lucid Diagnostics?

Which has better earnings & valuation, APT or LUCD?

Does the media favor APT or LUCD?

Is APT or LUCD more profitable?

Do insiders and institutionals hold more shares of APT or LUCD?

Do analysts rate APT or LUCD?

Which has more risk and volatility, APT or LUCD?

Summary

How does Alpha Pro Tech compare to Pro-Dex?

Is APT or PDEX more profitable?

Do institutionals and insiders hold more shares of APT or PDEX?

Which has stronger valuation & earnings, APT or PDEX?

Which has more risk and volatility, APT or PDEX?

Does the media refer more to APT or PDEX?

Do analysts recommend APT or PDEX?

Summary

How does Alpha Pro Tech compare to KORU Medical Systems?

Which has stronger earnings & valuation, APT or KRMD?

Do institutionals & insiders hold more shares of APT or KRMD?

Does the media refer more to APT or KRMD?

Do analysts rate APT or KRMD?

Which has more risk and volatility, APT or KRMD?

Is APT or KRMD more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

APT vs. The Competition

Alpha Pro Tech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools